Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma


Year of Award:
2016
Award Type:
R33
Project Number:
1R33CA196470-01A1
RFA Number:
RFA-CA-15-003
Technology Track:
Biospecimen Science Technologies
PI/Project Leader:
LIN, QIAO
Other PI or Project Leader:
N/A
Institution:
COLUMBIA UNIV NEW YORK MORNINGSIDE
Multiple myeloma (MM) is a plasma cell derived blood cancer that produces monoclonal immunoglobulins (M-Ig). Detection of minimal residual disease (MRD) is of great importance for MM care. All methods used for MRD detection are based on evaluation of plas